1. Home
  2. BIVI vs BEEM Comparison

BIVI vs BEEM Comparison

Compare BIVI & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • BEEM
  • Stock Information
  • Founded
  • BIVI 2013
  • BEEM 2006
  • Country
  • BIVI United States
  • BEEM United States
  • Employees
  • BIVI N/A
  • BEEM N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • BEEM Semiconductors
  • Sector
  • BIVI Health Care
  • BEEM Technology
  • Exchange
  • BIVI Nasdaq
  • BEEM Nasdaq
  • Market Cap
  • BIVI 49.8M
  • BEEM 49.3M
  • IPO Year
  • BIVI N/A
  • BEEM N/A
  • Fundamental
  • Price
  • BIVI $1.48
  • BEEM $2.44
  • Analyst Decision
  • BIVI Strong Buy
  • BEEM Strong Buy
  • Analyst Count
  • BIVI 1
  • BEEM 4
  • Target Price
  • BIVI $30.00
  • BEEM $9.00
  • AVG Volume (30 Days)
  • BIVI 596.3K
  • BEEM 149.3K
  • Earning Date
  • BIVI 02-11-2025
  • BEEM 04-15-2025
  • Dividend Yield
  • BIVI N/A
  • BEEM N/A
  • EPS Growth
  • BIVI N/A
  • BEEM N/A
  • EPS
  • BIVI N/A
  • BEEM N/A
  • Revenue
  • BIVI N/A
  • BEEM $60,883,000.00
  • Revenue This Year
  • BIVI N/A
  • BEEM N/A
  • Revenue Next Year
  • BIVI N/A
  • BEEM $24.12
  • P/E Ratio
  • BIVI N/A
  • BEEM N/A
  • Revenue Growth
  • BIVI N/A
  • BEEM 10.25
  • 52 Week Low
  • BIVI $1.04
  • BEEM $2.35
  • 52 Week High
  • BIVI $33.10
  • BEEM $7.68
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 32.72
  • BEEM 38.00
  • Support Level
  • BIVI $1.45
  • BEEM $2.35
  • Resistance Level
  • BIVI $1.88
  • BEEM $2.80
  • Average True Range (ATR)
  • BIVI 0.16
  • BEEM 0.15
  • MACD
  • BIVI -0.01
  • BEEM 0.02
  • Stochastic Oscillator
  • BIVI 5.08
  • BEEM 20.00

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About BEEM Beam Global

Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.

Share on Social Networks: